Results 1 to 10 of about 1,640,336 (314)

Evaluation of integrative oncology modalities for symptom management: a MASCC/SIO global survey. [PDF]

BMC Complement Med Ther
Chan A, Nasr R, Arcos D, Kagramanov D, Asuzu C, Bao T, Cheung YT, Kwon JH, Lacey J, Lee RT, Lustberg M, Ohaeri BM, Rao S, Soto-Perez-de-Celis E, Witt CM, Lopez AM.   +15 more
europepmc   +2 more sources

Evaluating large language models on a highly-specialized topic, radiation oncology physics [PDF]

Frontiers in Oncology, 2023
Purpose We present the first study to investigate Large Language Models (LLMs) in answering radiation oncology physics questions. Because popular exams like AP Physics, LSAT, and GRE have large test-taker populations and ample test preparation resources ...
J. Holmes, Zheng Liu, Lian-Cheng Zhang, Yuzhen Ding, T. Sio, L. Mcgee, J. Ashman, Xiang Li, Tianming Liu, Jiajian Shen, W. Liu   +10 more
semanticscholar   +1 more source

Acknowledgment to the Reviewers of Current Oncology in 2022

Current Oncology, 2023
High-quality academic publishing is built on rigorous peer review [...]
Current Oncology Editorial Office
doaj   +1 more source

Acknowledgment to Reviewers of Current Oncology in 2021

Current Oncology, 2022
Rigorous peer-reviews are the basis of high-quality academic publishing [...]
Current Oncology Editorial Office
doaj   +1 more source

Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.

The Journal of the National Comprehensive Cancer Network, 2022
Gastric cancer is the third leading cause of cancer-related deaths worldwide. Over 95% of gastric cancers are adenocarcinomas, which are typically classified based on anatomic location and histologic type.
J. Ajani, T. D’amico, D. Bentrem, J. Chao, David Cooke, Carlos Corvera, P. Das, P. Enzinger, T. Enzler, P. Fanta, F. Farjah, H. Gerdes, M. Gibson, S. Hochwald, W. Hofstetter, D. Ilson, R. Keswani, Sunnie S Kim, L. Kleinberg, S. Klempner, J. Lacy, Quan P. Ly, K. Matkowskyj, M. Mcnamara, M. Mulcahy, D. Outlaw, Haeseong Park, K. Perry, J. Pimiento, G. Poultsides, S. Reznik, R. Roses, V. Strong, Stacey Su, Hanlin L. Wang, G. Wiesner, C. Willett, D. Yakoub, H. Yoon, Nicole R Mcmillian, L. Pluchino   +40 more
semanticscholar   +1 more source

Leveraging Large Language Models for Decision Support in Personalized Oncology

JAMA Network Open, 2023
Key Points Question Can current conversational large language models (LLMs) be used as a tool for personalized decision-making in precision oncology? Findings In this diagnostic study, treatment option identification from 4 LLMs for 10 fictional patients
M. Benary, Xing David Wang, Max Schmidt, D. Soll, G. Hilfenhaus, M. Nassir, C. Sigler, M. Knödler, U. Keller, D. Beule, U. Keilholz, Ulf Leser, D. Rieke   +12 more
semanticscholar   +1 more source

Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.

The Journal of the National Comprehensive Cancer Network, 2021
This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Colon Cancer focuses on systemic therapy options for the treatment of metastatic colorectal cancer (mCRC), because important updates have recently been made to ...
A. Benson, A. Venook, M. Al-Hawary, M. Arain, Yi-Jen Chen, K. Ciombor, S. Cohen, H. Cooper, D. Deming, L. Farkas, I. Garrido-Laguna, J. Grem, A. Gunn, J. Hecht, S. Hoffe, J. Hubbard, S. Hunt, K. Johung, Natalie N. Kirilcuk, S. Krishnamurthi, W. Messersmith, J. Meyerhardt, E. Miller, M. Mulcahy, Steven J. Nurkin, M. Overman, A. Parikh, Hitendra R. H. Patel, K. Pedersen, L. Saltz, C. Schneider, D. Shibata, J. Skibber, C. Sofocleous, E. Stoffel, E. Stotsky-Himelfarb, C. Willett, K. Gregory, Lisa A. Gurski   +38 more
semanticscholar   +1 more source

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline.

Journal of Clinical Oncology, 2018
Purpose To increase awareness, outline strategies, and offer guidance on the recommended management of immune-related adverse events in patients treated with immune checkpoint inhibitor (ICPi) therapy.
J. Brahmer, C. Lacchetti, B. Schneider, M. Atkins, Kelly J. Brassil, J. Caterino, I. Chau, M. Ernstoff, Jennifer M. Gardner, P. Ginex, S. Hallmeyer, Jennifer Holter Chakrabarty, N. Leighl, J. Mammen, D. McDermott, A. Naing, L. Nastoupil, T. Phillips, Laura D. Porter, I. Puzanov, C. Reichner, B. Santomasso, Carole Seigel, A. Spira, M. Suarez‐Almazor, Yinghong Wang, J. Weber, J. Wolchok, John A Thompson   +28 more
semanticscholar   +1 more source

Clinical Practice Guidelines for Immune Checkpoint Inhibitor Therapy in Gynecological Tumors

Xiehe Yixue Zazhi, 2021
Immune checkpoint inhibitors (ICI) have shown efficacy for some patients with gynecological tumors, which are mainly used to treat persistent, recurrent, or metastatic patients.
Gynecological Oncology Society of Chinese Medical Association
doaj   +1 more source

Integrative Oncology Care of Symptoms of Anxiety and Depression in Adults With Cancer: Society for Integrative Oncology–ASCO Guideline

Journal of Clinical Oncology, 2023
PURPOSE To provide evidence-based recommendations to health care providers on integrative approaches to managing anxiety and depression symptoms in adults living with cancer.
L. Carlson, Nofisat Ismaila, E. Addington, Gary N. Asher, C. Atreya, L. Balneaves, J. Bradt, Nina Fuller-Shavel, Joseph Goodman, C. Hoffman, Alissa Huston, Ashwin Mehta, C. Paller, Kimberly Richardson, D. Seely, C. Siwik, J. Temel, J. Rowland   +17 more
semanticscholar   +1 more source